Intel stock reversed a 1.74% premarket decline on October 20, 2026, trading at $92.62, up approximately 0.6%, at 2:16 p.m. Eastern time. The recovery came a day after JPMorgan upgraded the chipmaker to Neutral and nine days before its scheduled third-quarter earnings release.
Key Takeaways
- Intel recovered its early losses, but the afternoon quotation was not a closing price.
- JPMorgan raised its recommendation while leaving its $85 price target unchanged.
- October 29 results will provide the next scheduled update on earnings and manufacturing progress.
Table of Contents
- Intel stock recovers after a volatile start
- JPMorgan upgrade stops short of a bullish recommendation
- Earnings expectations set the next test
- Conclusion
Intel stock recovers after a volatile start
The afternoon rebound followed a 2.43% gain on October 19, when Intel closed at $92.03. During the October 20 regular session, shares traded between approximately $88.78 and $93.73, showing how widely prices moved before the afternoon snapshot.
Other major semiconductor shares also declined in premarket trading, including AMD, Nvidia and Broadcom. The weakness coincided with renewed scrutiny of the spending and debt required to expand artificial intelligence infrastructure, although that backdrop does not establish a specific cause for Intel’s reversal.
Despite the recovery, Intel remained approximately 35% below its June high of $142.35. The two-session improvement therefore recovered only a small part of the stock’s retreat from that peak.
| Item | Details |
|---|---|
| Q3 2026 analyst revenue estimate | $16.50 billion |
| Q3 2026 company revenue guidance | $15.8 billion–$16.8 billion |
| Q3 2026 analyst adjusted EPS estimate | $0.40 |
| Q3 2026 company non-GAAP EPS guidance | $0.38 |
JPMorgan upgrade stops short of a bullish recommendation
JPMorgan analyst Harlan Sur upgraded Intel to Neutral from Underweight on October 19, describing its risk-reward profile as “much more balanced.” He cited improving execution under Chief Executive Lip-Bu Tan, advances in manufacturing and opportunities in server processors and custom chips.
The bank retained its $85 price target, below Intel’s October 20 afternoon trading price. The recommendation change was therefore not accompanied by a higher target.
Sur also highlighted continuing competitive pressure. He estimated that Intel’s share of x86 server processor revenue had fallen from 77% in 2022 to approximately 53%, and expected further share losses over the coming quarters. His more constructive assessment of execution did not mean those challenges had been resolved.
Earnings expectations set the next test
Intel’s third-quarter earnings schedule sets the release for October 29, 2026, promptly after the U.S. market closes. Management will hold its conference call at 2 p.m. Pacific daylight time, or 5 p.m. Eastern.
Analyst consensus calls for revenue within management’s July guidance range and adjusted earnings slightly above the company’s forecast. These are expectations, not reported third-quarter results.
Beyond the headline figures, the release will give investors an opportunity to assess server demand, margins and Intel Foundry’s profitability. Any management updates on 18A manufacturing yields, the 14A development roadmap or external customer commitments would help clarify the progress and cost of Intel’s turnaround.
Conclusion
Intel’s October 20 rebound preceded its quarterly results rather than responding to them. The next confirmed milestone is the October 29 release and conference call, when reported performance can be compared with management guidance and analyst expectations.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
